BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33853745)

  • 21. Pre-existing medication-related osteonecrosis of the jaw before dental extraction.
    Al-Sarraj M; Burns M; Patel V
    Br Dent J; 2023 Nov; 235(10):783-788. PubMed ID: 38001199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Type of Antiresorptive Treatment Influences the Time to Onset and the Surgical Outcome of Medication-Related Osteonecrosis of the Jaw.
    Pautke C; Wick A; Otto S; Hohlweg-Majert B; Hoffmann J; Ristow O
    J Oral Maxillofac Surg; 2021 Mar; 79(3):611-621. PubMed ID: 33166522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.
    Zirk M; Wenzel C; Buller J; Zöller JE; Zinser M; Peters F
    Clin Oral Investig; 2019 May; 23(5):2143-2151. PubMed ID: 30276516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meaning and Limitation of Cortical Bone Width Measurement with DentaScan in Medication-Related Osteonecrosis of the Jaws.
    Iwata E; Akashi M; Kishimoto M; Kusumoto J; Hasegawa T; Furudoi S; Komori T
    Kobe J Med Sci; 2017 Feb; 62(5):E114-E119. PubMed ID: 28289268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes and time to healing of medication-related osteonecrosis of the jaw based on image findings.
    Yasui T; Nagamine H; Tanaka K; Kimura M; Karube T; Kawana H; Onizawa K
    Dentomaxillofac Radiol; 2023 Jul; 52(5):20220352. PubMed ID: 37192041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
    Moreno-Rabié C; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; Gielen E; Van den Wyngaert T; Jacobs R
    Oral Dis; 2024 Apr; 30(3):1632-1642. PubMed ID: 36620873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
    Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
    Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
    Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
    J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Malignant Diseases and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis.
    Yao S; Ding X; Rong G; Zhou J; Zhang B
    J Craniofac Surg; 2023 Mar-Apr 01; 34(2):669-673. PubMed ID: 36184756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osseous changes in patients with medication-related osteonecrosis of the jaws.
    Gönen ZB; Yillmaz Asan C; Zararsiz G; Kiliç E; Alkan A
    Dentomaxillofac Radiol; 2018 Jan; 47(1):20170172. PubMed ID: 28871814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the Surgical Response of Bisphosphonate-Related Versus Denosumab-Related Osteonecrosis of the Jaws.
    Palla B; Burian E; Deek A; Scott C; Anderson J; Callahan N; Carlson ER
    J Oral Maxillofac Surg; 2021 May; 79(5):1045-1052. PubMed ID: 33358707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
    Yuan A; Munz A; Reinert S; Hoefert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?
    Moreno Rabie C; García-Larraín S; Contreras Diez de Medina D; Cabello-Salazar I; Fontenele RC; Van den Wyngaert T; Jacobs R
    Dentomaxillofac Radiol; 2023 Nov; 52(8):20230304. PubMed ID: 37870051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
    Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
    Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.